Cargando…
Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells
Angiogenesis is a process that drives breast cancer (BC) progression and metastasis, which is linked to the altered inflammatory process, particularly in triple-negative breast cancer (TNBC). In targeting inflammatory angiogenesis, natural compounds are a promising option for managing BC. Thus, this...
Autores principales: | Messeha, Samia S., Zarmouh, Najla O., Antonie, Lovely, Soliman, Karam F. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368383/ https://www.ncbi.nlm.nih.gov/pubmed/35955463 http://dx.doi.org/10.3390/ijms23158329 |
Ejemplares similares
-
Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020) -
The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2018) -
Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
por: Messeha, Samia S., et al.
Publicado: (2020) -
Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells
por: Messeha, Samia S., et al.
Publicado: (2020) -
The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells
por: Mendonca, Patricia, et al.
Publicado: (2019)